key: cord-0900959-lp7hd44l authors: Joshi, Amit; Joshi, Bhuwan Chandra; Mannan, M. Amin-ul; Kaushik, Vikas title: Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach date: 2020-04-29 journal: Inform Med Unlocked DOI: 10.1016/j.imu.2020.100338 sha: e7efcfd0fd15c30918a13fb02bddbb9987da0f9b doc_id: 900959 cord_uid: lp7hd44l Abstract A new virus termed SARS-COV-2 (causing COVID-19 disease) can exhibit a progressive, fatal impact on individuals. The World Health Organization (WHO) has declared the spread of the virus to be a global pandemic. Currently, there are over 1 million cases and over 100,000 confirmed deaths due to the virus. Hence, prophylactic and therapeutic strategies are promptly needed. In this study we report an epitope, ITLCFTLKR, which is biochemically fit to HLA allelic proteins. We propose that this could be used as a potential vaccine candidate against SARS-COV-2. A selected putative epitope and HLA-allelic complexes show not only better binding scores, but also RMSD values in the range of 0–1 Å. This epitope was found to have a 99.8% structural favorability as per Ramachandran-plot analysis. Similarly, a suitable range of IC50 values and population coverage was obtained to represent greater validation of T-cell epitope analysis. Stability analysis using MDWeb and half-life analysis using the ProtParam tool has confirmed that this epitope is well-selected. This new methodology of epitope-based vaccine prediction is fundamental and fast in application, ad can be economically beneficial and viable. The outbreak of COVID-19 in the Hubei region of the Chinese city of Wuhan [37] has resulted in a difficult situation for the global populace and for the World Health Organization (WHO). On 30 Jan 2020, WHO declared an emergency regarding COVID-19 spread, prevention, and control [28, 29] . As of 20 March 2020, there are over 240,000 cases and over 10,000 confirmed deaths, affecting 181 countries [9] . Present updates indicate that there are over 1 million confirmed cases and over 100,000 deaths worldwide [39] (information is obtained from https://www.worldometers.info/coronavirus/). The coronavirus is an RNA type virus with positive sense strand feature and is associated with the Coronaviridae family under order Nidovirales, and is found to be dispersed among Primate order, members of class Mammalia, and specifically in humans [31] . Severe acute respiratory syndrome coronavirus (SARS-CoV) [21, 22, 11] and Middle East respiratory disorder coronavirus (MERS-CoV), [7, 40] , classified as β-coronaviruses, are found to be related to the novel SARS-COV-2. Until now, there has been no efficacious therapy to regulate its spread [24] . Investigating its spread across continents and the vulnerability, there is an urgent need to craft vaccines for reinforcing immune defense against the SARS-COV-2 virus. One of the strategies to combat it is the development of vaccines that can initiate an adaptive immune response in humans. Here an attempt has been made to design an epitope based vaccine directed at SARS-COV-2, by analyzing the proteome of the virus by using Immuno-informatics tools. In this study, we deployed the use of various bioinformatics servers and Immuno-informatics tools for identifying and recognizing the T-cell epitopes from the intensive study of available protein sequences and structures that are related to SARS-COV-2. These epitope stretches can interact with MHC Class I and Class II HLA alleles; further validation of epitopes was analyzed by Ramachandran Plot analysis, Antigenicity parameters evaluation, Toxicity analysis, Population coverage, Molecular dynamics, and ProtParam analysis [19] . This approach is an excellent method in modern vaccine design, as it provides a lead over classical trial and error methods of wet labs [23] . We tried to identify T-cell epitopes that can elicit a robust immune response in the global human population and act as potential vaccine candidates. However, the ability of these epitopes to act as a vaccine candidate needs to be analyzed in Molecular biology lab studies. Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2. The greatest decline in virus expansion was noted following ORF3a removal. ORF7a encodes a 122-amino-acid type I transmembrane protein and structural studies disclose a packed seven-stranded β sandwich comparable in fold and topology to members of the immunoglobulin super family. SARS-CoV is an enveloped, positive-stranded RNA virus with a genome of around 29,700 bases. The genome incorporates at least 14 open reading frames (ORFs) that encode 28 proteins in three distinct classes: two large polyproteins P1a and P1ab that are cleaved into 16 non-structural proteins (nsp1-nsp16) during viral RNA synthesis; four structural proteins (S, E, M and N) that are necessary for viral entrance and gathering; and eight accessory proteins that are assumed to be dispensable for viral replication, but may facilitate viral assembly and take part in virulence and pathogenesis ( Figure 1 ). In our investigatory study, out of five, two proteins namely ORF-3a and ORF-7a specific to SARS-COV-2 were found to be putative T-cell epitope determinants that create useful information to distinguish, and these proteins are also important for viral replication and growth [41] . Both of these proteins may influence in viral pathogenesis and disease spread, although the literature lacks unanimity [43] . B-cell epitopes prediction is still considered to be untrustworthy for both linear and conformational epitopes as compared to T-cell epitopes. Furthermore, the Bcell epitopes do not elicit a strong antibody response. For this reason, only T-cell epitopes are considered in the present study. It is capable to produce CD4+ and CD8+ T-cells with longlasting response [45] . . In one of the recent studies, epitopes were designed, but they have focused on the single protein (i.e. SPIKE protein) to generate multiple epitopes like 13 for MHC I and 3 for MHC II [46]. We have analyzed multiple proteins to screen only effective epitopes based on various in-silico filters, to provide the most appropriate and authentic epitopes, which can be further tested in a wet lab. Five protein sequences were selected from NCBI-GenBank, listed in Table 1 ,for SARS-COV-2 based on their Allergenicity that relies on the Tanimoto similarity index score produced by The epitopes 3D structural findings were conducted by using the PEP-FOLD-3.5 server [25, 33, and MHC HLA Allelic peptides tertiary or 3D structure were obtained from the RCSB-PDB database [4]. The selected epitopes and HLA complexes were docked for calculating refined interactions and binding energies, along with atomic contact energy (ACE), by using two docking web-servers: and PatchDock [32]. Molecular dynamics study was conducted to analyze RMSD values and atomic fluctuations for all amino acids under the 100 ps time frame by deploying the MDWeb server. MDWeb server was deployed to analyze Coarse grained MD Brownian dynamics (C-alpha) with specifications Time: 100 ps, output frequency (steps) =10, force constant (kcal/mol Ǻ 2 ) = 40 , distance between alpha carbon atoms(Ǻ) =3.8 for both the interacting epitopes, and it was based on a GROMACS MD setup with solvation using an Amber-99sb* force-field [17]. The ToxinPred server [16] is utilized for determining the toxicity scoring of Epitopes for selecting non-toxic ones; also, the Ramachandran plot analysis was deployed by using the Non-allergen proteins selected (Table1) based on allergenicity scores (by deploying AllergenFP 1.0) New to NetMHCII PAN 3.2 and NETMHC 4.0 servers for determining 1-log50k value and affinity values for selecting the best possible pair of epitopes with their corresponding HLA alleles. In Table 2 and Table 3 , results for MHC Class I HLA and MHC Class II HLA alleles Epitope structures were obtained by using the PEP-FOLD-3.5 web-server; the HLA allele's structures were retrieved from the RCSB-PDB database. In Table 4 the crystal structure/model structure details with reference PDB-Id is provided. In Figures 3, 4, and 5 , interactions between a selected three T-Cell epitopes with respective MHC Class I and II HLA-Alleles via hydrogen bond formation and van der Waals interactions is depicted. After positive docking results, these epitopes were subjected to further Molecular dynamic simulation and biochemical parameters assessment. Figure 6 represents a graphical plot of binding scores for epitopes interacting with HLA-Alleles. ToxinPred 4.0 server results (in Table 6 .) represent Finalized T-cell Epitopes that were nontoxic from the biochemical perspective. Figures 8A and 8B suggest that most of the residues are allowed in a favored region; this gives more confidence in the structural conformation for targeted T-Cell Epitopes. MHCPred results ( We surmise that our screen can be more effective and useful. Primarily molecular docking reveals three Epitopes, but as we proceed to Molecular dynamic simulations, it reveals best interactions for two epitopes i.e., ITLCFTLKR and VYQLRARSV, with acceptable stability analyzed with the help of MDWeb and identified by using best available tools with easy-to-apply methods. One recent study was found to be focused on developing monoclonal antibodies like CR-3022 against the Spike protein of SARS-COV-2 that also exhibits interaction with ACE Satisfactory population coverage was observed for targeted epitopes -HLA allelic complexes at the worldwide, South Asia, and India level. The biochemical integrity in epitope structure was further evident by deploying Ramachandran plot analysis. Both epitopes were non-toxic, nonallergenic, and possess good antigenicity. In a similar study of the preliminary analysis of COVID-19 vaccine targets [1] the investigators tried to use the spike protein and nucleo-capsid protein sequences of SARS-COV that are homologous to some extant with SARS-COV-2 proteins to determine multiple different epitopes for Vaccine prediction, but in our study out of five two proteins namely ORF-3a and ORF-7a specific to SARS-COV-2 were found to be putative T-cell epitope determinants that create useful information; these proteins are also important for viral replication [41] . Both biochemical parameters, as well as an advanced HMM and ANN based algorithm in selected Immuno-informatics tools, were very useful to present a clear picture of predicted epitopes for crafting vaccine against SARS-COV-2. The only limitation that can be considered as future scope is that these easily synthesized peptides should be tested with In-vitro study for more practical validation. ITLCFTLKR epitope was selected for crafting and designing a vaccine against SARS-COV-2. This particular epitope has good antigenicity, exhibits active binding with MHC HLA-Alleles, and has maximum population coverage for different geographical regions. Therefore, this peptide can be further used in vaccine design against SARS-COV-2 after wet lab verification. This novel approach can also assist life science research groups to reduce time, monetary expenditures, as well as physical hit-trial efforts. Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies DINC 2.0: a new protein-peptide docking webserver using an incremental approach Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV The Protein Data Bank Predicting population coverage of T-cell epitope-based diagnostics and vaccines MolProbity: all-atom structure validation for macromolecular crystallography Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group AllergenFP: allergenicity prediction by descriptor fingerprints An interactive web-based dashboard to track COVID-19 in real time VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines Identification of a novel coronavirus in patients with severe acute respiratory syndrome Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection. Archives of Virology Insights into the Molecular Mechanisms of Protein-Ligand Interactions by Molecular Docking and Molecular Dynamics Simulation: A Case of Oligopeptide Binding Protein A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 MHCPred: a server for quantitative prediction of peptide-MHC binding In silico approach for predicting toxicity of peptides and proteins MDWeb and MDMoby: an integrated web-based platform for molecular dynamics simulations Improved methods for predicting peptide binding affinity to MHC class II molecules In Silico identification of epitope based peptide vaccine for Nipah virus Immune epitope database analysis resource. Nucleic acids research2012 A novel coronavirus associated with severe acute respiratory syndrome Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome Protective enterotoxigenic Escherichia coli antigens in a murine intranasal challenge model Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex Molecular immune pathogenesis and diagnosis of COVID-19 Identification of an epitope of SARS coronavirus nulceocapsid protein detail/30-01-2020-statement-on-the-second-meeting-of-theinternational-healthregulations-(2005)-emergency-committee-regarding-the-outbreak-of-novelcoronavirus-(2019-ncov) World-Health-Organization Director general's opening remark Virus Pathogen Database and Analysis Resource (ViPR): A Comprehensive Bioinformatics Database and Analysis Resource for the Coronavirus Research Community Clinical virology PatchDock and SymmDock: servers for rigid and symmetric docking Improved PEP-FOLD approach for peptide and miniprotein structure prediction PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirusspecific human monoclonal antibody CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice A novel coronavirus outbreak of global health concern Corona virus pathogenesis and the emerging pathogen severe acute respiratory syndrome corona virus Worldometers.info rapidly updating corona virus cases information and graphical representation website Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virus. Microbial pathogenesis Protein identification and analysis tools on the ExPASy server. InThe proteomics protocols handbook Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3 Differential stepwise evolution of SARS coronavirus functional proteins in different host species Fundamentals and methods for Tand B-cell epitope prediction Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach We acknowledge the support provided by Computational lab of Lovely professional University.